Sandoz Group reported higher sales for the second quarter, driven by a strong performance in its biosimilar segment and a return to growth in generics.
Source link
Sandoz Shares Climb After Biosimilar Sales Drive Growth
Date:
More like thisRelated
Jelly Roll + Bunnie Xo’s Stunning Nashville Mansion For Sale
The massive Nashville-area mansion that Jelly Roll and Bunnie...
The Latest Nuisance on Flights Is a Zoom Call at 30,000 Feet
Free, fast internet is finally rolling out on planes...